Aeluma CEO Jonathan Klamkin sells $1.34 million in company stock

Jonathan Klamkin, CEO and director of Aeluma, Inc., sold 100,000 shares of the company's common stock on September 21, 2026. The transaction, carried out under a Rule 10b5-1 plan, totaled $1,335,320 at an average price of $13.3532 per share. Klamkin's indirect ownership of Aeluma stock remains at 1,226,995 shares. The stock price currently stands at $13.18, marking a 5% decrease from the transaction price and a 59% drop from its 52-week high of $31.79.

Despite facing profitability challenges and a negative EPS of $0.52 over the past year, Aeluma's fair value suggests the stock is currently fairly valued. Additionally, Klamkin acquired 31,771 RSUs, which will vest in quarterly increments, and received 12,675 shares as a stock award in lieu of a cash bonus. He also disposed of 4,547 shares to cover tax obligations related to equity awards.

Klamkin has been granted 75,135 stock options, which vest in monthly increments and expire on September 21, 2036. Analysts maintain a bullish outlook with price targets ranging from $22 to $25, indicating potential upside. Aeluma reported a $582,000 revenue shortfall in Q4 2026, below Wall Street's forecast of $1.38 million. The company's fiscal year revenue remained flat at $4.5 million, but net losses widened due to higher operating costs.

Aeluma is focusing on the commercialization of AI datacom amid financial challenges, but analysts have not issued recent upgrades or downgrades, and the revenue miss has garnered attention from investors.